Oes Choledochofiberscope
Payments companies reported to CMS as associated with Oes Choledochofiberscope. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Oes Choledochofiberscope, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Oes Choledochofiberscope
These are the largest totals companies reported as associated with Oes Choledochofiberscope. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Morton | New Haven, CT | Surgery | $2,600.00 |
| Ting Yu Xu | Worcester, MA | Surgery | $1,710.00 |
| Joshua Landreneau | Columbia, MO | Surgery | $1,710.00 |
| Michael Potter | Worcester, MA | Surgery | $1,710.00 |
| Claudius Conrad | Urbana, IL | Surgical Oncology | $1,710.00 |
| Pei-Wen Lim | Scottsdale, AZ | Surgery | $1,710.00 |
| Eduardo Vega Pizarro | Boston, MA | Surgical Oncology | $1,710.00 |
| Raja Narayan | Loma Linda, CA | Surgical Oncology | $1,710.00 |
| Sameer Hirji | Boston, MA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $1,710.00 |
| John Frasca | Norfolk, MA | Surgery | $1,710.00 |
Prescribed Oes Choledochofiberscope?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.